HopeStage
Back to all studies
CompletedNCT05161351

Baclofen safety research with people receiving methadone

About this titleRead the official source — NCT05161351
Medication studyAges 21+United KingdomAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 21 years.

Listed locations
LondonSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: July 23, 2021
Recruitment status
Completed
Enrollment listed in the registry
16
Sponsor
Imperial College London
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United Kingdom
Age range
Over 21 Years
Official registry ID
NCT05161351
Official title
Show the full official title

Evaluating the Safety of Acute Baclofen in Methadone-maintained Individuals With Opiate Dependence. An Adaptive, Single-blind, Placebo-controlled Ascending Dose Study of Acute Baclofen on Safety Parameters in Opioid Dependence During Methadone-maintenance Treatment; a Pharmacokinetic-pharmacodynamic Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

London

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Imperial College London, a university.

Did this study involve medication?

Yes. The study involved medication, including Baclofen and Vitamin D3.

Who was this study for?

Listed age limits: from 21 years.

Want to explore more studies?

Explore studies